BioSpace News Archive

Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing.

The idea that oral health care is routine and unnecessary ignores decades of scientific research and is a disservice to patients

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today reported financial results for the quarter ended June 30, 2020 and provided a business update.

n Wednesday, August 12, 2020, BioSpyder Technologies, Inc. (“BioSpyder”) filed a civil action in the federal court for the Northern District of California, seeking a declaratory judgment that the BioSpyder TempO-Seq gene expression profiling assay does not infringe any valid claim in U.S. Patent No. 8,741,564

Novo Ventures, the ventures arm of Novo Holdings, today announces that its portfolio company, F2G Ltd, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, has secured US $60.8 million in new financing from new and existing investors.

Prometheus Biosciences, Inc., (“Prometheus”) a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with significant unmet medical needs in inflammatory bowel disease,

A clinical study in Western Australia will test the effects of a new nasal medication of synthetic cannabidiol to reduce the risk of post-surgical infections.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management program with Boston-based wearable technology firm WHOOP. The partnership will offer volunteers participating in the world’s first Phase III trials of an inactivated COVID-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics.

Individuals with sickle cell disease (SCD) who receive medical marijuana to treat pain may require fewer visits to the hospital, according to a new study in Blood Advances